Details

Last Funding Type

Series A

Last Funding Money Raised

€8M

Industries

Health Care,Medical,Medical Device,Neuroscience

Founded date

Jan 1, 2009

Number Of Employee

51 - 100

Operating Status

Active

Nyxoah is a health-technology company focused on the development and commercialization of innovative solutions and services to treat sleep disordered breathing conditions. Nyxoah's lead solution platform is based on the Genio® system, a validated, user-centered, next generation neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.